256 related articles for article (PubMed ID: 29763382)
1. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.
Kang JY; Kim JY; Kim KB; Park JW; Cho H; Hahm JY; Chae YC; Kim D; Kook H; Rhee S; Ha NC; Seo SB
FASEB J; 2018 Oct; 32(10):5737-5750. PubMed ID: 29763382
[TBL] [Abstract][Full Text] [Related]
2. Histone H3K79 demethylation by KDM2B facilitates proper DNA replication through PCNA dissociation from chromatin.
Kang JY; Park JW; Hahm JY; Jung H; Seo SB
Cell Prolif; 2020 Nov; 53(11):e12920. PubMed ID: 33029857
[TBL] [Abstract][Full Text] [Related]
3. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
[TBL] [Abstract][Full Text] [Related]
4. SRF is a nonhistone methylation target of KDM2B and SET7 in the regulation of skeletal muscle differentiation.
Kwon DH; Kang JY; Joung H; Kim JY; Jeong A; Min HK; Shin S; Lee YG; Kim YK; Seo SB; Kook H
Exp Mol Med; 2021 Feb; 53(2):250-263. PubMed ID: 33564100
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
[TBL] [Abstract][Full Text] [Related]
6. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1.
Gao R; Dong R; Du J; Ma P; Wang S; Fan Z
Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of
Gillman ACT; Parker G; Allday MJ; Bazot Q
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135119
[TBL] [Abstract][Full Text] [Related]
8. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.
Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T
J Biol Chem; 2021; 296():100213. PubMed ID: 33779563
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4.
Chavdoula E; Anastas V; La Ferlita A; Aldana J; Carota G; Spampinato M; Soysal B; Cosentini I; Parashar S; Sircar A; Nigita G; Sehgal L; Freitas MA; Tsichlis PN
Metabolism; 2024 Jan; 150():155719. PubMed ID: 37935302
[TBL] [Abstract][Full Text] [Related]
10. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
[TBL] [Abstract][Full Text] [Related]
11. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors.
Sasaki Y; Higashijima Y; Suehiro JI; Sugasawa T; Oguri-Nakamura E; Fukuhara S; Nagai N; Hirakawa Y; Wada Y; Nangaku M; Kanki Y
Biochem Biophys Res Commun; 2022 May; 605():16-23. PubMed ID: 35306360
[TBL] [Abstract][Full Text] [Related]
12. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
[TBL] [Abstract][Full Text] [Related]
13. KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.
Farcas AM; Blackledge NP; Sudbery I; Long HK; McGouran JF; Rose NR; Lee S; Sims D; Cerase A; Sheahan TW; Koseki H; Brockdorff N; Ponting CP; Kessler BM; Klose RJ
Elife; 2012 Dec; 1():e00205. PubMed ID: 23256043
[TBL] [Abstract][Full Text] [Related]
14. Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.
Tzatsos A; Paskaleva P; Lymperi S; Contino G; Stoykova S; Chen Z; Wong KK; Bardeesy N
J Biol Chem; 2011 Sep; 286(38):33061-9. PubMed ID: 21757686
[TBL] [Abstract][Full Text] [Related]
15. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J
J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849
[TBL] [Abstract][Full Text] [Related]
16. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia.
He J; Nguyen AT; Zhang Y
Blood; 2011 Apr; 117(14):3869-80. PubMed ID: 21310926
[TBL] [Abstract][Full Text] [Related]
17. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes.
He J; Shen L; Wan M; Taranova O; Wu H; Zhang Y
Nat Cell Biol; 2013 Apr; 15(4):373-84. PubMed ID: 23502314
[TBL] [Abstract][Full Text] [Related]
18. KDM2 proteins constrain transcription from CpG island gene promoters independently of their histone demethylase activity.
Turberfield AH; Kondo T; Nakayama M; Koseki Y; King HW; Koseki H; Klose RJ
Nucleic Acids Res; 2019 Sep; 47(17):9005-9023. PubMed ID: 31363749
[TBL] [Abstract][Full Text] [Related]
19. KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL.
Kurt IC; Sur I; Kaya E; Cingoz A; Kazancioglu S; Kahya Z; Toparlak OD; Senbabaoglu F; Kaya Z; Ozyerli E; Karahüseyinoglu S; Lack NA; Gümüs ZH; Onder TT; Bagci-Onder T
Cell Death Dis; 2017 Jun; 8(6):e2897. PubMed ID: 28661478
[TBL] [Abstract][Full Text] [Related]
20. KDM2B promotes IL-6 production and inflammatory responses through Brg1-mediated chromatin remodeling.
Zhou Q; Zhang Y; Wang B; Zhou W; Bi Y; Huai W; Chen X; Chen Y; Liu Z; Liu X; Zhan Z
Cell Mol Immunol; 2020 Aug; 17(8):834-842. PubMed ID: 31197256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
